Intratio
Loading...
Skip to main content
Model output · Signal date Oct. 14, 2026

Daily SignalsNeutral

2489 companies scored · 2026-10-14 run in progress: 1693 of ~5379 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D

Signal date 2026-10-14 Cut-offs from the 2026-10-13 run
Companies scored 2489 IC ≥ 0 · market cap ≥ $100M
Median forecast +3.08% Total · 90D
Long–short spread +4.99% Strong Buy minus Strong Sell, mean
Median IC 0.29 Spearman · 90D
Rating changes ▲ 44 ▼ 37 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · Neutral

66 companies

Sorted by 90D forecast ↓

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
51 OCULOCULAR THERAPEUTIX, INC Life Sciences 0.15 $1.6B Neutral +1.81% +2.57% ·
52 SABSSAB Biotherapeutics, Inc. Life Sciences 0.27 $244M Neutral +1.18% +2.53% ·
53 PAHCPHIBRO ANIMAL HEALTH CORP Life Sciences 0.47 $1.5B Neutral +0.76% +2.51% ·
54 VTRSViatris Inc Life Sciences 0.36 $20.1B Neutral +0.77% +2.50% ·
55 PEPGPepGen Inc. Life Sciences 0.38 $173M Neutral +1.10% +2.48% ·
56 AMRNAMARIN CORP PLC\UK Life Sciences 0.14 $4.9B Neutral +1.09% +2.46% ·
57 NWBONORTHWEST BIOTHERAPEUTICS INC Life Sciences 0.03 $277M Neutral +0.80% +2.44% ·
58 MSLESatellos Bioscience Inc. Life Sciences 0.39 $111M Neutral +0.86% +2.41% ·
59 AMPHAmphastar Pharmaceuticals, Inc. Life Sciences 0.47 $1.1B Neutral +0.68% +2.35% ·
60 LABSTANDARD BIOTOOLS INC. Life Sciences 0.27 $259M Neutral +0.85% +2.29% ·
61 MOLNMOLECULAR PARTNERS AG Life Sciences 0.02 $153M Neutral +0.63% +2.29% ·
62 AGIOAGIOS PHARMACEUTICALS, INC. Life Sciences 0.02 $1.8B Neutral +0.65% +2.27% ·
63 ZLABZai Lab Ltd Life Sciences 0.41 $27.6B Neutral +1.25% +2.19% ▲ 1
64 CRMDCorMedix Inc. Life Sciences 0.43 $576M Neutral +0.76% +2.16% ▲ 1
65 BLRXBioLineRx Ltd. Life Sciences 0.00 $5.7B Neutral +0.69% +2.15% ·
66 LFCRLIFECORE BIOMEDICAL, INC. \DE\ Life Sciences 0.04 $243M Neutral +0.93% +2.15% ·
51–66 of 66 Previous Next
Since the previous run

Rating changes

▲ 44▼ 37
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.